nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A6—coronary artery disease	0.00597	0.0577	CbGpPWpGaD
Milnacipran—SLC6A4—Synaptic Vesicle Pathway—DNM1L—coronary artery disease	0.00489	0.0473	CbGpPWpGaD
Milnacipran—SLC6A2—Amine compound SLC transporters—SLC6A6—coronary artery disease	0.00414	0.04	CbGpPWpGaD
Milnacipran—SLC6A4—Serotonin Transporter Activity—ITGB3—coronary artery disease	0.00289	0.0279	CbGpPWpGaD
Milnacipran—Levomilnacipran—CYP2C19—coronary artery disease	0.00273	0.588	CrCbGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00235	0.0227	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—PRDX6—coronary artery disease	0.00211	0.0204	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—CES3—coronary artery disease	0.00211	0.0204	CbGpPWpGaD
Milnacipran—SLC6A4—Synaptic Vesicle Pathway—SLC22A3—coronary artery disease	0.00203	0.0196	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—PRDX6—coronary artery disease	0.00181	0.0175	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—CES3—coronary artery disease	0.00181	0.0175	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.00178	0.0172	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—RAI1—coronary artery disease	0.00163	0.0158	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A6—coronary artery disease	0.00162	0.0157	CbGpPWpGaD
Milnacipran—SLC6A4—Serotonin Transporter Activity—IL1B—coronary artery disease	0.0016	0.0155	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SLC6A6—coronary artery disease	0.00136	0.0131	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.00135	0.0131	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.00124	0.0119	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.00124	0.0119	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—ITGB3—coronary artery disease	0.00123	0.0119	CbGpPWpGaD
Milnacipran—Pethidine—CYP2C19—coronary artery disease	0.00123	0.265	CrCbGaD
Milnacipran—SLC6A2—NRF2 pathway—SLC6A6—coronary artery disease	0.00117	0.0113	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTM2—coronary artery disease	0.00114	0.011	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—BHLHE40—coronary artery disease	0.0011	0.0107	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—AGT—coronary artery disease	0.00109	0.0105	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.00108	0.0104	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—ITGB3—coronary artery disease	0.00106	0.0102	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ID3—coronary artery disease	0.00105	0.0102	CbGpPWpGaD
Milnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—coronary artery disease	0.00104	0.0101	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—MAPK14—coronary artery disease	0.00104	0.01	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.00102	0.00989	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CREM—coronary artery disease	0.00101	0.00975	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GSTM2—coronary artery disease	0.000979	0.00946	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—AGT—coronary artery disease	0.000937	0.00906	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—SOD3—coronary artery disease	0.000918	0.00887	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GCLM—coronary artery disease	0.000918	0.00887	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—MAPK14—coronary artery disease	0.000894	0.00864	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TXNRD1—coronary artery disease	0.000889	0.00859	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.00087	0.00841	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GPX2—coronary artery disease	0.000818	0.00791	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—NRIP1—coronary artery disease	0.000797	0.00771	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTA1—coronary artery disease	0.000789	0.00763	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—SOD3—coronary artery disease	0.000789	0.00763	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GCLM—coronary artery disease	0.000789	0.00763	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—UTS2R—coronary artery disease	0.000764	0.00739	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TXNRD1—coronary artery disease	0.000764	0.00739	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.000757	0.00732	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.000736	0.00712	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ADORA1—coronary artery disease	0.000736	0.00711	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000717	0.00693	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GPX2—coronary artery disease	0.000703	0.0068	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000696	0.00673	CbGpPWpGaD
Milnacipran—Pethidine—ALB—coronary artery disease	0.000681	0.147	CrCbGaD
Milnacipran—SLC6A4—Monoamine Transport—IL1B—coronary artery disease	0.000681	0.00658	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GSTA1—coronary artery disease	0.000679	0.00656	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ARNTL—coronary artery disease	0.000668	0.00646	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GPX3—coronary artery disease	0.000663	0.00641	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000639	0.00617	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—UTS2—coronary artery disease	0.000604	0.00584	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GCLC—coronary artery disease	0.000598	0.00578	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—IL1B—coronary artery disease	0.000585	0.00566	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GPX3—coronary artery disease	0.00057	0.00551	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFB2—coronary artery disease	0.000567	0.00548	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000558	0.00539	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.000535	0.00517	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GCLC—coronary artery disease	0.000514	0.00497	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000511	0.00494	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CST3—coronary artery disease	0.00051	0.00493	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—HSPA1A—coronary artery disease	0.000499	0.00482	CbGpPWpGaD
Milnacipran—SLC6A4—Monoamine Transport—TNF—coronary artery disease	0.000494	0.00477	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFB2—coronary artery disease	0.000487	0.00471	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.000474	0.00459	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000473	0.00458	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GGT1—coronary artery disease	0.000467	0.00451	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—F7—coronary artery disease	0.000458	0.00443	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.00044	0.00425	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000438	0.00423	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000438	0.00423	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—HSPA1A—coronary artery disease	0.000429	0.00415	CbGpPWpGaD
Milnacipran—SLC6A2—Monoamine Transport—TNF—coronary artery disease	0.000425	0.00411	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000421	0.00407	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTP1—coronary artery disease	0.000419	0.00405	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFBR2—coronary artery disease	0.000419	0.00405	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—HMOX1—coronary artery disease	0.000414	0.004	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—GGT1—coronary artery disease	0.000401	0.00388	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—ADIPOQ—coronary artery disease	0.000395	0.00382	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000394	0.00381	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000392	0.00379	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000392	0.00379	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—HGF—coronary artery disease	0.000385	0.00373	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—GSTM1—coronary artery disease	0.000385	0.00373	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—HTR7—coronary artery disease	0.000377	0.00364	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000374	0.00362	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—AGER—coronary artery disease	0.000372	0.00359	CbGpPWpGaD
Milnacipran—Hypersensitivity—Niacin—coronary artery disease	0.00037	0.000415	CcSEcCtD
Milnacipran—Asthenia—Olmesartan—coronary artery disease	0.000369	0.000414	CcSEcCtD
Milnacipran—Headache—Clopidogrel—coronary artery disease	0.000369	0.000414	CcSEcCtD
Milnacipran—Rash—Lovastatin—coronary artery disease	0.000369	0.000413	CcSEcCtD
Milnacipran—Dermatitis—Lovastatin—coronary artery disease	0.000368	0.000413	CcSEcCtD
Milnacipran—Dyspepsia—Losartan—coronary artery disease	0.000368	0.000412	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.000368	0.00355	CbGpPWpGaD
Milnacipran—Headache—Lovastatin—coronary artery disease	0.000366	0.000411	CcSEcCtD
Milnacipran—Pruritus—Valsartan—coronary artery disease	0.000366	0.00041	CcSEcCtD
Milnacipran—Dry mouth—Ramipril—coronary artery disease	0.000366	0.00041	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000365	0.00353	CbGpPWpGaD
Milnacipran—Chest pain—Timolol—coronary artery disease	0.000365	0.00041	CcSEcCtD
Milnacipran—Vomiting—Ezetimibe—coronary artery disease	0.000365	0.000409	CcSEcCtD
Milnacipran—Hypersensitivity—Pravastatin—coronary artery disease	0.000364	0.000409	CcSEcCtD
Milnacipran—Gastrointestinal pain—Perindopril—coronary artery disease	0.000364	0.000408	CcSEcCtD
Milnacipran—Anxiety—Timolol—coronary artery disease	0.000364	0.000408	CcSEcCtD
Milnacipran—Pruritus—Olmesartan—coronary artery disease	0.000364	0.000408	CcSEcCtD
Milnacipran—Decreased appetite—Losartan—coronary artery disease	0.000363	0.000407	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000363	0.000407	CcSEcCtD
Milnacipran—Abdominal pain—Captopril—coronary artery disease	0.000363	0.000407	CcSEcCtD
Milnacipran—Body temperature increased—Captopril—coronary artery disease	0.000363	0.000407	CcSEcCtD
Milnacipran—Dizziness—Simvastatin—coronary artery disease	0.000362	0.000406	CcSEcCtD
Milnacipran—Rash—Ezetimibe—coronary artery disease	0.000362	0.000406	CcSEcCtD
Milnacipran—Dermatitis—Ezetimibe—coronary artery disease	0.000361	0.000405	CcSEcCtD
Milnacipran—SLC6A2—NRF2 pathway—GSTP1—coronary artery disease	0.000361	0.00349	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFBR2—coronary artery disease	0.000361	0.00349	CbGpPWpGaD
Milnacipran—Asthenia—Niacin—coronary artery disease	0.00036	0.000404	CcSEcCtD
Milnacipran—Fatigue—Losartan—coronary artery disease	0.00036	0.000404	CcSEcCtD
Milnacipran—Headache—Ezetimibe—coronary artery disease	0.000359	0.000403	CcSEcCtD
Milnacipran—Dry mouth—Timolol—coronary artery disease	0.000357	0.000401	CcSEcCtD
Milnacipran—Constipation—Losartan—coronary artery disease	0.000357	0.000401	CcSEcCtD
Milnacipran—Syncope—Lisinopril—coronary artery disease	0.000357	0.0004	CcSEcCtD
Milnacipran—Vomiting—Eplerenone—coronary artery disease	0.000357	0.0004	CcSEcCtD
Milnacipran—Leukopenia—Lisinopril—coronary artery disease	0.000356	0.0004	CcSEcCtD
Milnacipran—Nausea—Fenofibrate—coronary artery disease	0.000356	0.000399	CcSEcCtD
Milnacipran—SLC6A2—NRF2 pathway—HMOX1—coronary artery disease	0.000356	0.00344	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000356	0.00344	CbGpPWpGaD
Milnacipran—Pruritus—Niacin—coronary artery disease	0.000355	0.000398	CcSEcCtD
Milnacipran—Asthenia—Pravastatin—coronary artery disease	0.000355	0.000398	CcSEcCtD
Milnacipran—Gastrointestinal pain—Furosemide—coronary artery disease	0.000354	0.000397	CcSEcCtD
Milnacipran—Rash—Eplerenone—coronary artery disease	0.000354	0.000397	CcSEcCtD
Milnacipran—Urticaria—Perindopril—coronary artery disease	0.000354	0.000397	CcSEcCtD
Milnacipran—Hypersensitivity—Trandolapril—coronary artery disease	0.000354	0.000397	CcSEcCtD
Milnacipran—Dermatitis—Eplerenone—coronary artery disease	0.000354	0.000397	CcSEcCtD
Milnacipran—Diarrhoea—Valsartan—coronary artery disease	0.000353	0.000396	CcSEcCtD
Milnacipran—Shock—Ramipril—coronary artery disease	0.000352	0.000395	CcSEcCtD
Milnacipran—Hypersensitivity—Enalapril—coronary artery disease	0.000352	0.000395	CcSEcCtD
Milnacipran—Body temperature increased—Perindopril—coronary artery disease	0.000352	0.000395	CcSEcCtD
Milnacipran—Abdominal pain—Perindopril—coronary artery disease	0.000352	0.000395	CcSEcCtD
Milnacipran—Palpitations—Lisinopril—coronary artery disease	0.000352	0.000394	CcSEcCtD
Milnacipran—Diarrhoea—Olmesartan—coronary artery disease	0.000352	0.000394	CcSEcCtD
Milnacipran—Headache—Eplerenone—coronary artery disease	0.000352	0.000394	CcSEcCtD
Milnacipran—Nervous system disorder—Ramipril—coronary artery disease	0.000351	0.000394	CcSEcCtD
Milnacipran—Thrombocytopenia—Ramipril—coronary artery disease	0.000351	0.000393	CcSEcCtD
Milnacipran—Pruritus—Pravastatin—coronary artery disease	0.00035	0.000392	CcSEcCtD
Milnacipran—Loss of consciousness—Lisinopril—coronary artery disease	0.00035	0.000392	CcSEcCtD
Milnacipran—Nausea—Clopidogrel—coronary artery disease	0.00035	0.000392	CcSEcCtD
Milnacipran—Tachycardia—Ramipril—coronary artery disease	0.00035	0.000392	CcSEcCtD
Milnacipran—Skin disorder—Ramipril—coronary artery disease	0.000348	0.00039	CcSEcCtD
Milnacipran—Infection—Timolol—coronary artery disease	0.000348	0.00039	CcSEcCtD
Milnacipran—Vomiting—Simvastatin—coronary artery disease	0.000348	0.00039	CcSEcCtD
Milnacipran—Hypersensitivity—Telmisartan—coronary artery disease	0.000348	0.00039	CcSEcCtD
Milnacipran—Nausea—Lovastatin—coronary artery disease	0.000347	0.00039	CcSEcCtD
Milnacipran—Hyperhidrosis—Ramipril—coronary artery disease	0.000346	0.000388	CcSEcCtD
Milnacipran—Rash—Simvastatin—coronary artery disease	0.000345	0.000387	CcSEcCtD
Milnacipran—Dermatitis—Simvastatin—coronary artery disease	0.000345	0.000386	CcSEcCtD
Milnacipran—Asthenia—Trandolapril—coronary artery disease	0.000345	0.000386	CcSEcCtD
Milnacipran—Shock—Timolol—coronary artery disease	0.000345	0.000386	CcSEcCtD
Milnacipran—Urticaria—Furosemide—coronary artery disease	0.000344	0.000386	CcSEcCtD
Milnacipran—Diarrhoea—Niacin—coronary artery disease	0.000344	0.000385	CcSEcCtD
Milnacipran—Nervous system disorder—Timolol—coronary artery disease	0.000343	0.000385	CcSEcCtD
Milnacipran—Asthenia—Enalapril—coronary artery disease	0.000343	0.000385	CcSEcCtD
Milnacipran—Headache—Simvastatin—coronary artery disease	0.000343	0.000384	CcSEcCtD
Milnacipran—Body temperature increased—Furosemide—coronary artery disease	0.000342	0.000384	CcSEcCtD
Milnacipran—Abdominal pain—Furosemide—coronary artery disease	0.000342	0.000384	CcSEcCtD
Milnacipran—Gastrointestinal pain—Losartan—coronary artery disease	0.000342	0.000383	CcSEcCtD
Milnacipran—Dizziness—Valsartan—coronary artery disease	0.000342	0.000383	CcSEcCtD
Milnacipran—Anorexia—Ramipril—coronary artery disease	0.000342	0.000383	CcSEcCtD
Milnacipran—Nausea—Ezetimibe—coronary artery disease	0.000341	0.000382	CcSEcCtD
Milnacipran—Skin disorder—Timolol—coronary artery disease	0.00034	0.000381	CcSEcCtD
Milnacipran—Dizziness—Olmesartan—coronary artery disease	0.00034	0.000381	CcSEcCtD
Milnacipran—Pruritus—Trandolapril—coronary artery disease	0.00034	0.000381	CcSEcCtD
Milnacipran—Chest pain—Lisinopril—coronary artery disease	0.000339	0.00038	CcSEcCtD
Milnacipran—Hyperhidrosis—Timolol—coronary artery disease	0.000339	0.00038	CcSEcCtD
Milnacipran—Asthenia—Telmisartan—coronary artery disease	0.000339	0.00038	CcSEcCtD
Milnacipran—Pruritus—Enalapril—coronary artery disease	0.000338	0.000379	CcSEcCtD
Milnacipran—Diarrhoea—Pravastatin—coronary artery disease	0.000338	0.000379	CcSEcCtD
Milnacipran—Anxiety—Lisinopril—coronary artery disease	0.000338	0.000379	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000337	0.000377	CcSEcCtD
Milnacipran—Hypotension—Ramipril—coronary artery disease	0.000335	0.000375	CcSEcCtD
Milnacipran—Anorexia—Timolol—coronary artery disease	0.000334	0.000374	CcSEcCtD
Milnacipran—Pruritus—Telmisartan—coronary artery disease	0.000334	0.000374	CcSEcCtD
Milnacipran—Nausea—Eplerenone—coronary artery disease	0.000334	0.000374	CcSEcCtD
Milnacipran—Dizziness—Niacin—coronary artery disease	0.000332	0.000372	CcSEcCtD
Milnacipran—Urticaria—Losartan—coronary artery disease	0.000332	0.000372	CcSEcCtD
Milnacipran—Dry mouth—Lisinopril—coronary artery disease	0.000331	0.000372	CcSEcCtD
Milnacipran—SLC6A2—NRF2 pathway—GSTM1—coronary artery disease	0.000331	0.0032	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—HGF—coronary artery disease	0.000331	0.0032	CbGpPWpGaD
Milnacipran—Body temperature increased—Losartan—coronary artery disease	0.00033	0.00037	CcSEcCtD
Milnacipran—Abdominal pain—Losartan—coronary artery disease	0.00033	0.00037	CcSEcCtD
Milnacipran—Asthenia—Captopril—coronary artery disease	0.000329	0.000369	CcSEcCtD
Milnacipran—Diarrhoea—Trandolapril—coronary artery disease	0.000329	0.000368	CcSEcCtD
Milnacipran—Vomiting—Valsartan—coronary artery disease	0.000328	0.000368	CcSEcCtD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000328	0.00317	CbGpPWpGaD
Milnacipran—Diarrhoea—Enalapril—coronary artery disease	0.000327	0.000367	CcSEcCtD
Milnacipran—Hypotension—Timolol—coronary artery disease	0.000327	0.000367	CcSEcCtD
Milnacipran—Dizziness—Pravastatin—coronary artery disease	0.000327	0.000367	CcSEcCtD
Milnacipran—Vomiting—Olmesartan—coronary artery disease	0.000327	0.000367	CcSEcCtD
Milnacipran—Rash—Valsartan—coronary artery disease	0.000326	0.000365	CcSEcCtD
Milnacipran—Dermatitis—Valsartan—coronary artery disease	0.000325	0.000365	CcSEcCtD
Milnacipran—Nausea—Simvastatin—coronary artery disease	0.000325	0.000364	CcSEcCtD
Milnacipran—Pruritus—Captopril—coronary artery disease	0.000325	0.000364	CcSEcCtD
Milnacipran—Rash—Olmesartan—coronary artery disease	0.000324	0.000363	CcSEcCtD
Milnacipran—Insomnia—Ramipril—coronary artery disease	0.000324	0.000363	CcSEcCtD
Milnacipran—Dermatitis—Olmesartan—coronary artery disease	0.000324	0.000363	CcSEcCtD
Milnacipran—Headache—Valsartan—coronary artery disease	0.000324	0.000363	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000323	0.00313	CbGpPWpGaD
Milnacipran—Diarrhoea—Telmisartan—coronary artery disease	0.000323	0.000362	CcSEcCtD
Milnacipran—Infection—Lisinopril—coronary artery disease	0.000323	0.000362	CcSEcCtD
Milnacipran—Headache—Olmesartan—coronary artery disease	0.000322	0.000361	CcSEcCtD
Milnacipran—Paraesthesia—Ramipril—coronary artery disease	0.000322	0.000361	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.000322	0.00311	CbGpPWpGaD
Milnacipran—Shock—Lisinopril—coronary artery disease	0.00032	0.000358	CcSEcCtD
Milnacipran—Asthenia—Perindopril—coronary artery disease	0.00032	0.000358	CcSEcCtD
Milnacipran—SLC6A2—NRF2 pathway—AGER—coronary artery disease	0.00032	0.00309	CbGpPWpGaD
Milnacipran—Dyspnoea—Ramipril—coronary artery disease	0.000319	0.000358	CcSEcCtD
Milnacipran—Vomiting—Niacin—coronary artery disease	0.000319	0.000358	CcSEcCtD
Milnacipran—Hypersensitivity—Furosemide—coronary artery disease	0.000319	0.000358	CcSEcCtD
Milnacipran—Somnolence—Ramipril—coronary artery disease	0.000319	0.000357	CcSEcCtD
Milnacipran—Thrombocytopenia—Lisinopril—coronary artery disease	0.000318	0.000357	CcSEcCtD
Milnacipran—Dizziness—Trandolapril—coronary artery disease	0.000318	0.000356	CcSEcCtD
Milnacipran—Tachycardia—Lisinopril—coronary artery disease	0.000317	0.000356	CcSEcCtD
Milnacipran—Insomnia—Timolol—coronary artery disease	0.000317	0.000355	CcSEcCtD
Milnacipran—Rash—Niacin—coronary artery disease	0.000317	0.000355	CcSEcCtD
Milnacipran—Dermatitis—Niacin—coronary artery disease	0.000316	0.000355	CcSEcCtD
Milnacipran—Dizziness—Enalapril—coronary artery disease	0.000316	0.000355	CcSEcCtD
Milnacipran—Skin disorder—Lisinopril—coronary artery disease	0.000316	0.000354	CcSEcCtD
Milnacipran—Dyspepsia—Ramipril—coronary artery disease	0.000315	0.000354	CcSEcCtD
Milnacipran—Pruritus—Perindopril—coronary artery disease	0.000315	0.000353	CcSEcCtD
Milnacipran—Headache—Niacin—coronary artery disease	0.000315	0.000353	CcSEcCtD
Milnacipran—Paraesthesia—Timolol—coronary artery disease	0.000315	0.000353	CcSEcCtD
Milnacipran—Vomiting—Pravastatin—coronary artery disease	0.000314	0.000353	CcSEcCtD
Milnacipran—Hyperhidrosis—Lisinopril—coronary artery disease	0.000314	0.000352	CcSEcCtD
Milnacipran—Diarrhoea—Captopril—coronary artery disease	0.000314	0.000352	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000314	0.00303	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000314	0.00303	CbGpPWpGaD
Milnacipran—Dyspnoea—Timolol—coronary artery disease	0.000312	0.00035	CcSEcCtD
Milnacipran—Dizziness—Telmisartan—coronary artery disease	0.000312	0.00035	CcSEcCtD
Milnacipran—Rash—Pravastatin—coronary artery disease	0.000312	0.00035	CcSEcCtD
Milnacipran—Dermatitis—Pravastatin—coronary artery disease	0.000312	0.000349	CcSEcCtD
Milnacipran—Decreased appetite—Ramipril—coronary artery disease	0.000311	0.000349	CcSEcCtD
Milnacipran—Somnolence—Timolol—coronary artery disease	0.000311	0.000349	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—SIRT1—coronary artery disease	0.000311	0.00301	CbGpPWpGaD
Milnacipran—Asthenia—Furosemide—coronary artery disease	0.000311	0.000348	CcSEcCtD
Milnacipran—Headache—Pravastatin—coronary artery disease	0.00031	0.000347	CcSEcCtD
Milnacipran—Anorexia—Lisinopril—coronary artery disease	0.00031	0.000347	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000309	0.000347	CcSEcCtD
Milnacipran—Fatigue—Ramipril—coronary artery disease	0.000309	0.000346	CcSEcCtD
Milnacipran—Dyspepsia—Timolol—coronary artery disease	0.000308	0.000346	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000308	0.00298	CbGpPWpGaD
Milnacipran—Hypersensitivity—Losartan—coronary artery disease	0.000308	0.000345	CcSEcCtD
Milnacipran—Nausea—Valsartan—coronary artery disease	0.000307	0.000344	CcSEcCtD
Milnacipran—Pruritus—Furosemide—coronary artery disease	0.000306	0.000344	CcSEcCtD
Milnacipran—Constipation—Ramipril—coronary artery disease	0.000306	0.000343	CcSEcCtD
Milnacipran—Nausea—Olmesartan—coronary artery disease	0.000305	0.000342	CcSEcCtD
Milnacipran—Vomiting—Trandolapril—coronary artery disease	0.000305	0.000342	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000305	0.00295	CbGpPWpGaD
Milnacipran—Diarrhoea—Perindopril—coronary artery disease	0.000305	0.000342	CcSEcCtD
Milnacipran—Decreased appetite—Timolol—coronary artery disease	0.000304	0.000341	CcSEcCtD
Milnacipran—Vomiting—Enalapril—coronary artery disease	0.000304	0.000341	CcSEcCtD
Milnacipran—Hypotension—Lisinopril—coronary artery disease	0.000304	0.00034	CcSEcCtD
Milnacipran—Dizziness—Captopril—coronary artery disease	0.000303	0.00034	CcSEcCtD
Milnacipran—Rash—Trandolapril—coronary artery disease	0.000303	0.00034	CcSEcCtD
Milnacipran—Dermatitis—Trandolapril—coronary artery disease	0.000303	0.000339	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Timolol—coronary artery disease	0.000302	0.000339	CcSEcCtD
Milnacipran—Fatigue—Timolol—coronary artery disease	0.000302	0.000339	CcSEcCtD
Milnacipran—Rash—Enalapril—coronary artery disease	0.000302	0.000338	CcSEcCtD
Milnacipran—Dermatitis—Enalapril—coronary artery disease	0.000301	0.000338	CcSEcCtD
Milnacipran—Headache—Trandolapril—coronary artery disease	0.000301	0.000337	CcSEcCtD
Milnacipran—Vomiting—Telmisartan—coronary artery disease	0.0003	0.000336	CcSEcCtD
Milnacipran—Asthenia—Losartan—coronary artery disease	0.0003	0.000336	CcSEcCtD
Milnacipran—Headache—Enalapril—coronary artery disease	0.0003	0.000336	CcSEcCtD
Milnacipran—Nausea—Niacin—coronary artery disease	0.000298	0.000335	CcSEcCtD
Milnacipran—Rash—Telmisartan—coronary artery disease	0.000297	0.000334	CcSEcCtD
Milnacipran—Dermatitis—Telmisartan—coronary artery disease	0.000297	0.000333	CcSEcCtD
Milnacipran—Diarrhoea—Furosemide—coronary artery disease	0.000296	0.000332	CcSEcCtD
Milnacipran—Pruritus—Losartan—coronary artery disease	0.000296	0.000331	CcSEcCtD
Milnacipran—Headache—Telmisartan—coronary artery disease	0.000296	0.000331	CcSEcCtD
Milnacipran—Dizziness—Perindopril—coronary artery disease	0.000295	0.00033	CcSEcCtD
Milnacipran—Insomnia—Lisinopril—coronary artery disease	0.000294	0.000329	CcSEcCtD
Milnacipran—Nausea—Pravastatin—coronary artery disease	0.000294	0.000329	CcSEcCtD
Milnacipran—Gastrointestinal pain—Ramipril—coronary artery disease	0.000293	0.000328	CcSEcCtD
Milnacipran—Paraesthesia—Lisinopril—coronary artery disease	0.000292	0.000327	CcSEcCtD
Milnacipran—Vomiting—Captopril—coronary artery disease	0.000292	0.000327	CcSEcCtD
Milnacipran—Dyspnoea—Lisinopril—coronary artery disease	0.00029	0.000325	CcSEcCtD
Milnacipran—Rash—Captopril—coronary artery disease	0.000289	0.000324	CcSEcCtD
Milnacipran—Dermatitis—Captopril—coronary artery disease	0.000289	0.000324	CcSEcCtD
Milnacipran—Somnolence—Lisinopril—coronary artery disease	0.000289	0.000324	CcSEcCtD
Milnacipran—Headache—Captopril—coronary artery disease	0.000287	0.000322	CcSEcCtD
Milnacipran—Gastrointestinal pain—Timolol—coronary artery disease	0.000286	0.000321	CcSEcCtD
Milnacipran—Dizziness—Furosemide—coronary artery disease	0.000286	0.000321	CcSEcCtD
Milnacipran—Dyspepsia—Lisinopril—coronary artery disease	0.000286	0.000321	CcSEcCtD
Milnacipran—Diarrhoea—Losartan—coronary artery disease	0.000286	0.000321	CcSEcCtD
Milnacipran—Nausea—Trandolapril—coronary artery disease	0.000285	0.00032	CcSEcCtD
Milnacipran—Urticaria—Ramipril—coronary artery disease	0.000285	0.000319	CcSEcCtD
Milnacipran—Nausea—Enalapril—coronary artery disease	0.000284	0.000319	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000284	0.00274	CbGpPWpGaD
Milnacipran—Vomiting—Perindopril—coronary artery disease	0.000283	0.000318	CcSEcCtD
Milnacipran—Body temperature increased—Ramipril—coronary artery disease	0.000283	0.000318	CcSEcCtD
Milnacipran—Abdominal pain—Ramipril—coronary artery disease	0.000283	0.000318	CcSEcCtD
Milnacipran—Decreased appetite—Lisinopril—coronary artery disease	0.000282	0.000317	CcSEcCtD
Milnacipran—Rash—Perindopril—coronary artery disease	0.000281	0.000315	CcSEcCtD
Milnacipran—Dermatitis—Perindopril—coronary artery disease	0.000281	0.000315	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000281	0.000315	CcSEcCtD
Milnacipran—Nausea—Telmisartan—coronary artery disease	0.00028	0.000314	CcSEcCtD
Milnacipran—Fatigue—Lisinopril—coronary artery disease	0.00028	0.000314	CcSEcCtD
Milnacipran—Headache—Perindopril—coronary artery disease	0.000279	0.000313	CcSEcCtD
Milnacipran—Urticaria—Timolol—coronary artery disease	0.000278	0.000312	CcSEcCtD
Milnacipran—Constipation—Lisinopril—coronary artery disease	0.000278	0.000312	CcSEcCtD
Milnacipran—Body temperature increased—Timolol—coronary artery disease	0.000277	0.00031	CcSEcCtD
Milnacipran—Abdominal pain—Timolol—coronary artery disease	0.000277	0.00031	CcSEcCtD
Milnacipran—Dizziness—Losartan—coronary artery disease	0.000276	0.00031	CcSEcCtD
Milnacipran—Vomiting—Furosemide—coronary artery disease	0.000275	0.000309	CcSEcCtD
Milnacipran—Rash—Furosemide—coronary artery disease	0.000273	0.000306	CcSEcCtD
Milnacipran—Dermatitis—Furosemide—coronary artery disease	0.000273	0.000306	CcSEcCtD
Milnacipran—Nausea—Captopril—coronary artery disease	0.000273	0.000306	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000272	0.00263	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000272	0.00263	CbGpPWpGaD
Milnacipran—Headache—Furosemide—coronary artery disease	0.000271	0.000304	CcSEcCtD
Milnacipran—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000266	0.000298	CcSEcCtD
Milnacipran—Vomiting—Losartan—coronary artery disease	0.000266	0.000298	CcSEcCtD
Milnacipran—Nausea—Perindopril—coronary artery disease	0.000265	0.000297	CcSEcCtD
Milnacipran—Hypersensitivity—Ramipril—coronary artery disease	0.000264	0.000296	CcSEcCtD
Milnacipran—Rash—Losartan—coronary artery disease	0.000263	0.000295	CcSEcCtD
Milnacipran—Dermatitis—Losartan—coronary artery disease	0.000263	0.000295	CcSEcCtD
Milnacipran—Headache—Losartan—coronary artery disease	0.000262	0.000293	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000258	0.0025	CbGpPWpGaD
Milnacipran—Urticaria—Lisinopril—coronary artery disease	0.000258	0.000289	CcSEcCtD
Milnacipran—Hypersensitivity—Timolol—coronary artery disease	0.000258	0.000289	CcSEcCtD
Milnacipran—Nausea—Furosemide—coronary artery disease	0.000257	0.000288	CcSEcCtD
Milnacipran—Asthenia—Ramipril—coronary artery disease	0.000257	0.000288	CcSEcCtD
Milnacipran—Body temperature increased—Lisinopril—coronary artery disease	0.000257	0.000288	CcSEcCtD
Milnacipran—Abdominal pain—Lisinopril—coronary artery disease	0.000257	0.000288	CcSEcCtD
Milnacipran—Pruritus—Ramipril—coronary artery disease	0.000253	0.000284	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000252	0.00244	CbGpPWpGaD
Milnacipran—Asthenia—Timolol—coronary artery disease	0.000251	0.000282	CcSEcCtD
Milnacipran—Nausea—Losartan—coronary artery disease	0.000248	0.000278	CcSEcCtD
Milnacipran—Pruritus—Timolol—coronary artery disease	0.000248	0.000278	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—LEP—coronary artery disease	0.000246	0.00237	CbGpPWpGaD
Milnacipran—Diarrhoea—Ramipril—coronary artery disease	0.000245	0.000275	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000241	0.00233	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000241	0.00233	CbGpPWpGaD
Milnacipran—Diarrhoea—Timolol—coronary artery disease	0.00024	0.000269	CcSEcCtD
Milnacipran—Hypersensitivity—Lisinopril—coronary artery disease	0.000239	0.000268	CcSEcCtD
Milnacipran—Dizziness—Ramipril—coronary artery disease	0.000237	0.000266	CcSEcCtD
Milnacipran—Asthenia—Lisinopril—coronary artery disease	0.000233	0.000261	CcSEcCtD
Milnacipran—Dizziness—Timolol—coronary artery disease	0.000232	0.00026	CcSEcCtD
Milnacipran—Pruritus—Lisinopril—coronary artery disease	0.00023	0.000258	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—NOS2—coronary artery disease	0.000229	0.00221	CbGpPWpGaD
Milnacipran—Vomiting—Ramipril—coronary artery disease	0.000228	0.000255	CcSEcCtD
Milnacipran—Rash—Ramipril—coronary artery disease	0.000226	0.000253	CcSEcCtD
Milnacipran—Dermatitis—Ramipril—coronary artery disease	0.000226	0.000253	CcSEcCtD
Milnacipran—Headache—Ramipril—coronary artery disease	0.000224	0.000252	CcSEcCtD
Milnacipran—Vomiting—Timolol—coronary artery disease	0.000223	0.00025	CcSEcCtD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000222	0.00215	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000222	0.00215	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000222	0.00215	CbGpPWpGaD
Milnacipran—Diarrhoea—Lisinopril—coronary artery disease	0.000222	0.000249	CcSEcCtD
Milnacipran—Rash—Timolol—coronary artery disease	0.000221	0.000248	CcSEcCtD
Milnacipran—Dermatitis—Timolol—coronary artery disease	0.000221	0.000247	CcSEcCtD
Milnacipran—Headache—Timolol—coronary artery disease	0.000219	0.000246	CcSEcCtD
Milnacipran—Dizziness—Lisinopril—coronary artery disease	0.000215	0.000241	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—PPARG—coronary artery disease	0.000214	0.00207	CbGpPWpGaD
Milnacipran—Nausea—Ramipril—coronary artery disease	0.000213	0.000239	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—GSK3B—coronary artery disease	0.000213	0.00206	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—CREB1—coronary artery disease	0.000211	0.00204	CbGpPWpGaD
Milnacipran—Nausea—Timolol—coronary artery disease	0.000208	0.000233	CcSEcCtD
Milnacipran—Vomiting—Lisinopril—coronary artery disease	0.000207	0.000232	CcSEcCtD
Milnacipran—Rash—Lisinopril—coronary artery disease	0.000205	0.00023	CcSEcCtD
Milnacipran—Dermatitis—Lisinopril—coronary artery disease	0.000205	0.000229	CcSEcCtD
Milnacipran—Headache—Lisinopril—coronary artery disease	0.000204	0.000228	CcSEcCtD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.0002	0.00193	CbGpPWpGaD
Milnacipran—Nausea—Lisinopril—coronary artery disease	0.000193	0.000216	CcSEcCtD
Milnacipran—SLC6A4—Circadian rythm related genes—SERPINE1—coronary artery disease	0.000193	0.00186	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000192	0.00185	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000191	0.00185	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000171	0.00165	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000167	0.00161	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000165	0.00159	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000162	0.00157	CbGpPWpGaD
Milnacipran—SLC6A4—NRF2 pathway—TGFB1—coronary artery disease	0.000157	0.00152	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000156	0.00151	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000145	0.0014	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000139	0.00134	CbGpPWpGaD
Milnacipran—SLC6A2—NRF2 pathway—TGFB1—coronary artery disease	0.000135	0.00131	CbGpPWpGaD
Milnacipran—SLC6A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	0.000135	0.0013	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000123	0.00119	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000114	0.0011	CbGpPWpGaD
Milnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—coronary artery disease	0.000112	0.00109	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000109	0.00105	CbGpPWpGaD
Milnacipran—SLC6A4—Circadian rythm related genes—IL6—coronary artery disease	9.16e-05	0.000886	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	8.63e-05	0.000834	CbGpPWpGaD
Milnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—coronary artery disease	6.84e-05	0.000661	CbGpPWpGaD
